Medicover

Near-term
Medicover commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by 2030 from a 2024 base year. Medicover also commits to reduce scope 3 GHG emissions from purchased goods and services 51.6% per EUR value added within the same timeframe.

Long-term
Medicover commits to reduce absolute scope 1 and 2 GHG emissions 90.0% by 2050 from a 2024 base year. Medicover also commits to reduce absolute scope 3 GHG emissions 90.0% within the same timeframe.

“Medicover’s most powerful and positive impact comes from the healthcare we provide to people in need, and we remain deeply committed to enabling more and more people to benefit from that care. We are very proud that, in parallel with expanding access to healthcare, we have validated targets for reductions in our GHG emissions, and that we have reaffirmed our existing goal of achieving net zero by 2050” said John Stubbington, CEO Medicover.

For further information, please contact:
Hanna Bjellquist, Head of Investor Relations

Phone: +46 703 033 272
Mail: hanna.bjellquist@medicover.com

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points, and the largest markets are Poland, Germany, Romania and India. In 2024, Medicover had revenue of EUR 2,092 million and more than 47,000 employees. For more information, go to www.medicover.com